SPARC, His, Cynomolgus
SPARC, His, Cynomolgus

Immobilized SPARC, His, Cynomolgus, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-SPARC Antibody, hFc Tag with the EC50 of 69.7ng/ml determined by ELISA.

SPARC, His, Cynomolgus

The purity of SPARC, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

SPARC, His, Cynomolgus

SPARC, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

SPARC, His, Cynomolgus

Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM40) is one of the most abundant non-collagenous protein expressed in mineralized tissues.The capacity of SPARC to influence pathways involved in extracellular matrix assembly such as procollagen processing and collagen fibril formation as well as the capacity to influence osteoblast differentiation and osteoclast activity will be addressed.
Z04920
¥72,752.00

Ask us a question
Product Introduction
Species Cynomolgus
Protein Construction
SPARC (Ala18-Ile303)
Accession # G7P8R2		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 33.82 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 43-48 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • SPARC, His, Cynomolgus
    • SPARC, His, Cynomolgus

    Immobilized SPARC, His, Cynomolgus, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-SPARC Antibody, hFc Tag with the EC50 of 69.7ng/ml determined by ELISA.

  • SPARC, His, Cynomolgus
    • SPARC, His, Cynomolgus

    The purity of SPARC, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

  • SPARC, His, Cynomolgus
    • SPARC, His, Cynomolgus

    SPARC, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM40) is one of the most abundant non-collagenous protein expressed in mineralized tissues.The capacity of SPARC to influence pathways involved in extracellular matrix assembly such as procollagen processing and collagen fibril formation as well as the capacity to influence osteoblast differentiation and osteoclast activity will be addressed.
Synonyms SPARC; BM-40; ON; EGM_15571

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.